Answers are grounded in this paper and cite their sources.
Lipedema is frequently underrecognized and confused with obesity, venous insufficiency, or lymphedema, resulting in delayed diagnosis. This study aimed to characterize the diagnostic journey, pain profile, treatment goals, and retrospectively perceived enablement in women with lipedema. This single-center cross-sectional study included 107 women with lipedema diagnosed clinically according to the German S2k guideline and international Delphi consensus criteria. Diagnostic history was assessed using a structured form. Pain intensity, neuropathic pain features, treatment goals, and perceived enablement were evaluated using the Visual Analog Scale (VAS), Douleur Neuropathique 4 questionnaire (DN4), Patient Benefit Index-Lymphedema/Lipedema needs and goals section, and Patient Enablement Instrument (PEI), respectively. Mean age was 49.6 ± 13.2 years. Mean intervals from symptom onset to first consultation and from first consultation to diagnosis were 10.1 ± 10.8 and 5.3 ± 7.0 years, respectively, with a total diagnostic delay of 15.4 ± 12.1 years. Participants consulted 3.7 ± 1.7 physicians before diagnosis. The mean VAS score was 7.10 ± 2.11 on a 0–10 scale, and 50.5% of participants reported severe pain (VAS 8–10). The mean DN4 score was 5.02 ± 2.38, and 71.0% (95% CI 61.8–78.8) screened positive for neuropathic pain features. The mean PEI score was 5.25 ± 3.17 (possible range 0–12). Goals focused on reducing swelling, tightness, and pain and improving mobility. The median post-consultation delay was 0 years when physical medicine and rehabilitation was consulted first, 1 year for cardiovascular surgery, 4 years for orthopedics, and 9.5 years for internal medicine; because most participants had been diagnosed recently, these differences largely reflected how long ago the first consultation had taken place and should be interpreted descriptively. Women with lipedema experienced prolonged diagnostic journeys and a substantial pain burden. Disproportionate, painful limb enlargement that persists despite weight loss should prompt clinicians, particularly in the specialties most often consulted first, to consider lipedema and refer patients to a clinic experienced in its diagnosis. After diagnosis, systematic pain assessment, including screening for neuropathic features, should be part of routine care.
No takes yet. Share an insight, caveat, or question.
Çetin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: